Adaptive Insulin Management for Specialized Environments

Publication ID: 24-11857314_0004_PTD
Published: November 07, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Adaptive Insulin Management for Specialized Environments,” Published Technical Disclosure No. 24-11857314_0004_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857314_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,314.

Summary of the Inventive Concept

The present inventive concept adapts insulin management systems for specific, narrow markets or unique operational environments, providing tailored solutions for high-security facilities, disaster relief situations, extreme weather conditions, trauma patients, and remote or isolated areas.

Background and Problem Solved

The original insulin management patent addresses the critical issue of manually calculating insulin doses, but it lacks consideration for specialized environments that require adapted solutions. The present inventive concept addresses this limitation by providing customized insulin management systems that cater to specific operational environments, ensuring more effective and efficient patient care.

Detailed Description of the Inventive Concept

The inventive concept comprises a suite of specialized insulin management systems, each tailored to a specific environment. For high-security facilities, the system incorporates a secure database and communication protocol to protect patient records and ensure authorized access. In disaster relief situations, the system utilizes a portable glucose monitoring system and cloud-based insulin dosing algorithm to provide real-time dosing recommendations. For extreme weather conditions, the system features a weather-resistant housing and backup power source to ensure continuous operation. For patients with fluctuating blood sugars due to trauma, the system employs a machine learning algorithm to analyze patient data and adjust insulin dosing recommendations based on the patient's response to treatment. Finally, for remote or isolated areas, the system incorporates a satellite-based communication system to transmit patient data and receive insulin dosing recommendations from a remote clinical decision support system.

Novelty and Inventive Step

The present inventive concept introduces novel adaptations to insulin management systems, addressing specific challenges posed by unique operational environments. The inventive step lies in the customized solutions provided for each environment, which are not obvious from the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include integrating wearable glucose monitoring devices, utilizing artificial intelligence to predict insulin dosing needs, or incorporating environmental sensors to adjust insulin dosing recommendations based on external factors.

Potential Commercial Applications and Market

The present inventive concept has significant commercial potential in various industries, including healthcare, disaster relief, and defense. The target market includes high-security facilities, disaster relief organizations, extreme weather response teams, trauma centers, and remote or isolated healthcare providers.

Field of Art

Medical informatics and digital healthcare systems, specifically insulin management and glucose monitoring technologies. Requires expertise in medical device design, data processing, algorithmic treatment protocols, and healthcare software integration

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or clinical informatics specialist with advanced degrees, proficient in medical device design, data analytics, machine learning applications in healthcare, and understanding of patient monitoring systems

Obviousness Rationale

A PHOSITA would recognize that the PTD's specialized insulin management systems represent predictable extensions of the source patent's core glucose monitoring and insulin administration methodology. The disclosed variations apply known technological strategies like secure communication protocols, machine learning algorithms, and environmental adaptations to the fundamental insulin management framework. These adaptations represent logical engineering solutions to context-specific challenges in medical technology deployment.

Obvious Combinations & Variations

Source Patent Element
Computer-implemented method for receiving sequential glucose measurements
PTD Variation
Satellite-based communication system for transmitting patient data in remote areas
Obviousness Reasoning
Extending data transmission methods to remote environments is a predictable solution using known telecommunications technologies, representing a routine design modification
Source Patent Element
Electronic medical record system integration for glucose measurements
PTD Variation
Secure database with communication protocol for high-security facilities
Obviousness Reasoning
Implementing enhanced data security measures is an obvious enhancement for sensitive medical information, utilizing standard cybersecurity techniques
Source Patent Element
Insulin dosing calculation based on glucose measurements
PTD Variation
Machine learning algorithm to adjust insulin recommendations based on patient response
Obviousness Reasoning
Applying machine learning to medical dosing protocols is a known technique for personalizing treatment, representing an incremental technological improvement
Source Patent Element
Continuous glucose monitoring system
PTD Variation
Portable glucose monitoring system for disaster relief scenarios
Obviousness Reasoning
Adapting existing monitoring technologies for emergency contexts represents a straightforward engineering solution with predictable functionality
Source Patent Element
Computer-implemented method for insulin administration
PTD Variation
Weather-resistant housing with backup power for extreme conditions
Obviousness Reasoning
Designing medical devices with environmental resilience is a standard engineering practice, representing a routine design modification
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857314, a Person Having Ordinary Skill In The Art would find the technical variations disclosed in the Published Technical Disclosure to represent obvious extensions of the prior art, lacking inventive step under 35 U.S.C. ยง 103. The proposed adaptations constitute predictable applications of known medical informatics techniques to specialized environmental contexts, thereby rendering potential patent claims obvious and non-patentable.

Original Patent Information

Patent NumberUS 11,857,314
TitleInsulin management
Assignee(s)Aseko, Inc.